Metastatic malignant insulinoma in a patient with type 2 diabetes mellitus: Case presentation and literature review

Elias S. Siraj, George Samuel, Suzan Saber, Samuel Samuel, Amir Hamrahian, S. Sethu K. Reddy

Research output: Contribution to journalArticle

Abstract

Objective: To describe the occurrence of metastatic malignant insulinoma in a patient with preexisting type 2 diabetes mellitus. Methods: We present a detailed case report, with clinical, biochemical, and imaging findings, and summarize the data from 21 similar cases in the literature. Results: The occurrence of malignant insulinoma in a patient with preexisting diabetes is very rare and thus can be a diagnostic challenge. In our patient with type 2 diabetes, endogenous hyperinsulinism was confirmed by demonstrating elevated insulin and C-peptide levels during hypoglycemic episodes in the absence of sulfonylurea on a blood screen. Abdominal computed tomographic scan and magnetic resonance imaging revealed a pancreatic mass as well as metastatic lesions in the liver. The pancreatic mass was removed and confirmed to be a malignant insulinoma. This procedure was followed by disappearance of the hypoglycemic episodes as well as the diabetes for a few months. On follow-up, however, more metastatic lesions appeared in conjunction with a protracted course of hypoglycemia that necessitated treatment with antihypoglycemic agents and, 3 years after the initial surgical intervention, culminated in the death of the patient. Conclusion: Our patient is one of the few subjects known to have a malignant insulinoma in conjunction with preexisting diabetes. A high degree of suspicion for the presence of an insulinoma should be maintained when unexplained hypoglycemic episodes occur in a patient with previously stable diabetes.

Original languageEnglish (US)
Pages (from-to)411-416
Number of pages6
JournalEndocrine Practice
Volume12
Issue number4
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Insulinoma
Type 2 Diabetes Mellitus
Hypoglycemic Agents
C-Peptide
Hyperinsulinism
Hypoglycemia
Magnetic Resonance Imaging
Insulin
Liver

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Metastatic malignant insulinoma in a patient with type 2 diabetes mellitus : Case presentation and literature review. / Siraj, Elias S.; Samuel, George; Saber, Suzan; Samuel, Samuel; Hamrahian, Amir; Reddy, S. Sethu K.

In: Endocrine Practice, Vol. 12, No. 4, 01.01.2006, p. 411-416.

Research output: Contribution to journalArticle

Siraj, Elias S. ; Samuel, George ; Saber, Suzan ; Samuel, Samuel ; Hamrahian, Amir ; Reddy, S. Sethu K. / Metastatic malignant insulinoma in a patient with type 2 diabetes mellitus : Case presentation and literature review. In: Endocrine Practice. 2006 ; Vol. 12, No. 4. pp. 411-416.
@article{30776221168e445db89d687f2f9c3db3,
title = "Metastatic malignant insulinoma in a patient with type 2 diabetes mellitus: Case presentation and literature review",
abstract = "Objective: To describe the occurrence of metastatic malignant insulinoma in a patient with preexisting type 2 diabetes mellitus. Methods: We present a detailed case report, with clinical, biochemical, and imaging findings, and summarize the data from 21 similar cases in the literature. Results: The occurrence of malignant insulinoma in a patient with preexisting diabetes is very rare and thus can be a diagnostic challenge. In our patient with type 2 diabetes, endogenous hyperinsulinism was confirmed by demonstrating elevated insulin and C-peptide levels during hypoglycemic episodes in the absence of sulfonylurea on a blood screen. Abdominal computed tomographic scan and magnetic resonance imaging revealed a pancreatic mass as well as metastatic lesions in the liver. The pancreatic mass was removed and confirmed to be a malignant insulinoma. This procedure was followed by disappearance of the hypoglycemic episodes as well as the diabetes for a few months. On follow-up, however, more metastatic lesions appeared in conjunction with a protracted course of hypoglycemia that necessitated treatment with antihypoglycemic agents and, 3 years after the initial surgical intervention, culminated in the death of the patient. Conclusion: Our patient is one of the few subjects known to have a malignant insulinoma in conjunction with preexisting diabetes. A high degree of suspicion for the presence of an insulinoma should be maintained when unexplained hypoglycemic episodes occur in a patient with previously stable diabetes.",
author = "Siraj, {Elias S.} and George Samuel and Suzan Saber and Samuel Samuel and Amir Hamrahian and Reddy, {S. Sethu K.}",
year = "2006",
month = "1",
day = "1",
doi = "10.4158/EP.12.4.411",
language = "English (US)",
volume = "12",
pages = "411--416",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "4",

}

TY - JOUR

T1 - Metastatic malignant insulinoma in a patient with type 2 diabetes mellitus

T2 - Case presentation and literature review

AU - Siraj, Elias S.

AU - Samuel, George

AU - Saber, Suzan

AU - Samuel, Samuel

AU - Hamrahian, Amir

AU - Reddy, S. Sethu K.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Objective: To describe the occurrence of metastatic malignant insulinoma in a patient with preexisting type 2 diabetes mellitus. Methods: We present a detailed case report, with clinical, biochemical, and imaging findings, and summarize the data from 21 similar cases in the literature. Results: The occurrence of malignant insulinoma in a patient with preexisting diabetes is very rare and thus can be a diagnostic challenge. In our patient with type 2 diabetes, endogenous hyperinsulinism was confirmed by demonstrating elevated insulin and C-peptide levels during hypoglycemic episodes in the absence of sulfonylurea on a blood screen. Abdominal computed tomographic scan and magnetic resonance imaging revealed a pancreatic mass as well as metastatic lesions in the liver. The pancreatic mass was removed and confirmed to be a malignant insulinoma. This procedure was followed by disappearance of the hypoglycemic episodes as well as the diabetes for a few months. On follow-up, however, more metastatic lesions appeared in conjunction with a protracted course of hypoglycemia that necessitated treatment with antihypoglycemic agents and, 3 years after the initial surgical intervention, culminated in the death of the patient. Conclusion: Our patient is one of the few subjects known to have a malignant insulinoma in conjunction with preexisting diabetes. A high degree of suspicion for the presence of an insulinoma should be maintained when unexplained hypoglycemic episodes occur in a patient with previously stable diabetes.

AB - Objective: To describe the occurrence of metastatic malignant insulinoma in a patient with preexisting type 2 diabetes mellitus. Methods: We present a detailed case report, with clinical, biochemical, and imaging findings, and summarize the data from 21 similar cases in the literature. Results: The occurrence of malignant insulinoma in a patient with preexisting diabetes is very rare and thus can be a diagnostic challenge. In our patient with type 2 diabetes, endogenous hyperinsulinism was confirmed by demonstrating elevated insulin and C-peptide levels during hypoglycemic episodes in the absence of sulfonylurea on a blood screen. Abdominal computed tomographic scan and magnetic resonance imaging revealed a pancreatic mass as well as metastatic lesions in the liver. The pancreatic mass was removed and confirmed to be a malignant insulinoma. This procedure was followed by disappearance of the hypoglycemic episodes as well as the diabetes for a few months. On follow-up, however, more metastatic lesions appeared in conjunction with a protracted course of hypoglycemia that necessitated treatment with antihypoglycemic agents and, 3 years after the initial surgical intervention, culminated in the death of the patient. Conclusion: Our patient is one of the few subjects known to have a malignant insulinoma in conjunction with preexisting diabetes. A high degree of suspicion for the presence of an insulinoma should be maintained when unexplained hypoglycemic episodes occur in a patient with previously stable diabetes.

UR - http://www.scopus.com/inward/record.url?scp=33750104997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750104997&partnerID=8YFLogxK

U2 - 10.4158/EP.12.4.411

DO - 10.4158/EP.12.4.411

M3 - Article

C2 - 16901797

AN - SCOPUS:33750104997

VL - 12

SP - 411

EP - 416

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 4

ER -